NEW BRUNSWICK, New Jersey: Johnson & Johnson said on Monday (Jul 6) it was slashing the price of its version of tuberculosis drug bedaquiline to US$340 from US$400, for a six-month treatment, in low- and middle-income countries, to scale up its use during the COVID-19 pandemic. J&J’s bedaquiline …
